Achieving value and sustainability in prescribing medication: consultation

Closes 8 Sep 2024

This service needs cookies enabled.

Amiodarone

Recommendations

  • prescribe only if for an exception or indication named in this guidance
  • consider deprescribing in individuals currently prescribed this item where appropriate
  • prescribe only if no other item or intervention is clinically appropriate
  • prescribe only if no other item or intervention is available

 

Exceptions:

  • May be suitable in individuals prior and post cardioversion or in specific individuals who also have heart failure or left ventricular impairment.
  • Must be initiated by a specialist and only continued for individuals where other treatments cannot be used, have failed or is in line with NICE Guidance CG180.
  • Where there is an existing cohort of individuals taking amiodarone it is recommended that these individuals are reviewed to ensure that prescribing remains safe and appropriate, and necessary monitoring is in place.
19a. Do you agree or disagree with the recommendation that amiodarone is only prescribed for an exception or indication named in this guidance?
19b. Do you agree or disagree with the recommendation to deprescribe amiodarone in individuals where appropriate?
19c. Do you agree or disagree with the recommendation to only prescribe amiodarone if no other item or intervention is clinically appropriate or available?
19d. Please provide any further comments on the recommendations for amiodarone.